AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Edwards Lifesciences Corporation

$84.37 -$0.96 (-1.13%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$86.77
Day Range
$83.81$87.75
Year Range
$72.3$96.29
Market Cap
48.58B
AVG Volume
4.38M
Trailing/Forward PE
48.49/24.92
PEG ratio
3.78
Dividend Yield
-
Next Earnings Date
2026-10-29
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
02B4B6B8B2016201720182019202020212022202320242025
EW Revenue (USD) by year
PeriodRevenue (USD)
20256.07B
20245.46B
20235.26B
20225.38B
20215.23B
20204.39B
20194.35B
20183.72B
20173.44B
20162.96B
Net Income (USD)
02B4B6B2016201720182019202020212022202320242025
EW Net Income (USD) by year
PeriodNet Income (USD)
20251.07B
20244.17B
20231.4B
20221.52B
20211.5B
2020823.4M
20191.05B
2018722.2M
2017622.1M
2016569.5M
Operating Income (USD)
0500M1B1.5B2B2016201720182019202020212022202320242025
EW Operating Income (USD) by year
PeriodOperating Income (USD)
20251.62B
20241.38B
20231.48B
20221.7B
20211.61B
20201.3B
20191.2B
20181.09B
20171.02B
2016790.2M
EBITDA (USD)
0500M1B1.5B2B2016201720182019202020212022202320242025
EW EBITDA (USD) by year
PeriodEBITDA (USD)
20251.39B
20241.75B
20231.58B
20221.94B
20211.87B
20201.05B
20191.28B
2018841.1M
20171.12B
2016848.9M
Cash Flows (USD)
0500M1B1.5B2016201720182019202020212022202320242025
EW Cash Flows (USD) by year
PeriodCash Flows (USD)
20251.33B
2024289.9M
2023629.5M
2022953.4M
20211.4B
2020647M
2019901M
2018685.1M
2017825.2M
2016487M
EPS (USD)
024682016201720182019202020212022202320242025
EW EPS (USD) by year
PeriodEPS (USD)
20251.83
20246.97
20232.3
20222.44
20212.39
20201.3
20191.64
20181.12
20170.96
20160.87
Expenses (USD)
01B2B3B4BR&DSG&ACapex2016201720182019202020212022202320242025
EW Expenses (USD) by year
PeriodExpenses (USD)
20253.42B
20243.1B
20232.9B
20222.78B
20212.73B
20202.4B
20192.28B
20181.95B
20171.71B
20161.57B
Cash & Debt (USD)
02B4B6BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
EW Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20254.23B
20243.98B
20231.63B
20221.22B
20211.47B
20201.4B
20191.52B
2018956.5M
20171.34B
20161.27B
Debt ratios
-0.6-0.4-0.2-020182019202020212022202320242025
EW Debt ratios by year
PeriodDebt ratios
2025-0.53
2024-0.46
2023-0.15
2022-0.09
2021-0.15
2020-0.16
2019-0.2
2018-0.1
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
EW Margins by year
PeriodMargins
202578.11%
202479.07%
202378.09%
202278.28%
202176.57%
202074.94%
201973.43%
201875.23%
201774.43%
201673.3%
Return on Capital
0%20%40%60%2016201720182019202020212022202320242025
EW Return on Capital by year
PeriodReturn on Capital
202510.35%
202441.46%
202320.87%
202226.21%
202125.76%
202018%
201925.24%
201823%
201720.77%
201621.74%
Shares Outstanding
0200M400M600M800M2016201720182019202020212022202320242025
EW Shares Outstanding by year
PeriodShares Outstanding
2025580.4M
2024589.8M
2023605.2M
2022612.9M
2021624.1M
2020623.5M
2019626.4M
2018624.3M
2017632.4M
2016641.1M
Book Value Per Share (USD)
051015202016201720182019202020212022202320242025
EW Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
202517.81
202417.06
202311.1
20229.47
20219.35
20207.34
20196.62
20185.03
20174.74
20164.09
Total Assets (USD)
05B10B15B2016201720182019202020212022202320242025
EW Total Assets (USD) by year
PeriodTotal Assets (USD)
202513.7B
202413.06B
20239.36B
20228.29B
20218.5B
20207.24B
20196.49B
20185.32B
20175.7B
20164.51B
Employee Count
05K10K15K20K2016201720182019202020212022202320242025
EW Employee Count by year
PeriodEmployee Count
202516K
202415.8K
202319.8K
202217.3K
202115.7K
202014.9K
201913.9K
201812.8K
201712.2K
201611.1K
PE Ratio
0204060med 11.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW PE Ratio by year
PeriodPE Ratio
Sep 2648.39
Sep 2651.57
Aug 2651.74
Aug 2651.5
Aug 2652.54
Aug 2651.46
Jul 2645.62
Jul 2643.8
Jul 2645.44
Jul 2648.87
Jul 2650.02
Jun 2648.11
Jun 2646.3
Jun 2645.11
Jun 2645.56
May 2645.83
May 2645.46
May 2643.13
May 2642.38
May 2645.55
Apr 2645.64
Apr 2643.93
Apr 2642.24
Apr 2643.96
Mar 2643.03
Mar 2644.75
Mar 2644.37
Mar 2644.28
Feb 2646.9
Feb 2634.19
Feb 2632.51
Feb 2633.73
Jan 2634.86
Jan 2635.85
Jan 2636.14
Jan 2636.48
Jan 2636.56
Dec 2537.22
Dec 2536.71
Dec 2535.6
Dec 2536.93
Nov 2537.14
Nov 2536.48
Nov 2536.98
Nov 2535.73
Oct 2511.68
Oct 2510.78
Oct 2510.57
Oct 2510.47
Oct 2510.92
Sep 2510.8
Sep 2510.54
Sep 2510.99
Sep 2511.46
Aug 2511.52
Aug 2511.59
Aug 2511.09
Aug 2511.1
Aug 2511.14
Jul 2511.24
Jul 2510.74
Jul 2510.96
Jul 2510.79
Jun 2510.99
Jun 2510.37
Jun 2510.56
Jun 2510.89
May 2510.99
May 2510.53
May 2510.96
May 2510.35
May 2510.69
Apr 2510.75
Apr 2510.11
Apr 259.81
Apr 259.81
Mar 2510.02
Mar 259.96
Mar 259.8
Mar 259.94
Feb 2510.12
Feb 2510.53
Feb 2510.95
Feb 2510.11
Jan 2510.41
Jan 259.91
Jan 2510.03
Jan 2510.55
Jan 2510.62
Dec 2410.87
Dec 2410.75
Dec 2410.54
Dec 2410.28
Nov 2410.25
Nov 2410.13
Nov 249.74
Nov 249.52
Nov 2427.66
Oct 2428.41
Oct 2428.77
Free Cash Flow Yield
0%1%2%3%med 1.45%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 262.95%
Sep 262.77%
Aug 262.76%
Aug 262.77%
Aug 262.72%
Aug 262.77%
Jul 262.19%
Jul 262.28%
Jul 262.19%
Jul 262.04%
Jul 261.99%
Jun 262.07%
Jun 262.15%
Jun 262.21%
Jun 262.19%
May 262.18%
May 262.19%
May 262.31%
May 262.35%
May 262.74%
Apr 262.73%
Apr 262.84%
Apr 262.95%
Apr 262.84%
Mar 262.9%
Mar 262.79%
Mar 262.81%
Mar 262.82%
Feb 262.66%
Feb 261.72%
Feb 261.81%
Feb 261.75%
Jan 261.69%
Jan 261.64%
Jan 261.63%
Jan 261.62%
Jan 261.61%
Dec 251.58%
Dec 251.61%
Dec 251.66%
Dec 251.6%
Nov 251.59%
Nov 251.62%
Nov 251.59%
Nov 251.65%
Oct 251.26%
Oct 251.36%
Oct 251.39%
Oct 251.4%
Oct 251.34%
Sep 251.36%
Sep 251.39%
Sep 251.34%
Sep 251.28%
Aug 251.27%
Aug 251.27%
Aug 251.32%
Aug 251.32%
Aug 251.4%
Jul 251.39%
Jul 251.45%
Jul 251.43%
Jul 251.45%
Jun 251.42%
Jun 251.51%
Jun 251.48%
Jun 251.44%
May 251.42%
May 251.48%
May 251.43%
May 251.51%
May 250.65%
Apr 250.65%
Apr 250.69%
Apr 250.71%
Apr 250.71%
Mar 250.69%
Mar 250.7%
Mar 250.71%
Mar 250.7%
Feb 250.69%
Feb 251.15%
Feb 251.1%
Feb 251.2%
Jan 251.16%
Jan 251.22%
Jan 251.21%
Jan 251.15%
Jan 251.14%
Dec 241.11%
Dec 241.12%
Dec 241.15%
Dec 241.18%
Nov 241.18%
Nov 241.19%
Nov 241.24%
Nov 241.27%
Nov 241.32%
Oct 241.29%
Oct 241.27%
Price to Sales
77.588.59med 7.99Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Price to Sales by year
PeriodPrice to Sales
Sep 267.47
Sep 267.96
Aug 267.98
Aug 267.95
Aug 268.11
Aug 267.94
Jul 267.91
Jul 267.59
Jul 267.88
Jul 268.47
Jul 268.67
Jun 268.34
Jun 268.03
Jun 267.82
Jun 267.9
May 267.95
May 267.88
May 267.48
May 267.35
May 268.03
Apr 268.05
Apr 267.75
Apr 267.45
Apr 267.75
Mar 267.59
Mar 267.89
Mar 267.83
Mar 267.81
Feb 268.27
Feb 267.93
Feb 267.54
Feb 267.82
Jan 268.09
Jan 268.31
Jan 268.38
Jan 268.46
Jan 268.48
Dec 258.63
Dec 258.51
Dec 258.26
Dec 258.57
Nov 258.61
Nov 258.46
Nov 258.58
Nov 258.29
Oct 258.51
Oct 257.86
Oct 257.71
Oct 257.63
Oct 257.96
Sep 257.87
Sep 257.68
Sep 258.01
Sep 258.36
Aug 258.4
Aug 258.45
Aug 258.08
Aug 258.09
Aug 258.41
Jul 258.48
Jul 258.11
Jul 258.27
Jul 258.14
Jun 258.29
Jun 257.82
Jun 257.96
Jun 258.21
May 258.29
May 257.95
May 258.27
May 257.81
May 258.18
Apr 258.22
Apr 257.73
Apr 257.5
Apr 257.5
Mar 257.67
Mar 257.62
Mar 257.49
Mar 257.6
Feb 257.74
Feb 258.2
Feb 258.53
Feb 257.87
Jan 258.11
Jan 257.72
Jan 257.81
Jan 258.22
Jan 258.27
Dec 248.47
Dec 248.37
Dec 248.2
Dec 248
Nov 247.98
Nov 247.89
Nov 247.58
Nov 247.41
Nov 247.78
Oct 247.99
Oct 248.1
EV/EBITDA
2025303540med 24.63Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW EV/EBITDA by year
PeriodEV/EBITDA
Sep 2629.27
Sep 2631.34
Aug 2631.46
Aug 2631.3
Aug 2631.98
Aug 2631.27
Jul 2633
Jul 2631.59
Jul 2632.86
Jul 2635.5
Jul 2636.38
Jun 2634.92
Jun 2633.52
Jun 2632.61
Jun 2632.95
May 2633.16
May 2632.88
May 2631.09
May 2630.51
May 2632.5
Apr 2632.57
Apr 2631.25
Apr 2629.95
Apr 2631.28
Mar 2630.56
Mar 2631.88
Mar 2631.59
Mar 2631.52
Feb 2633.54
Feb 2624.97
Feb 2623.66
Feb 2624.62
Jan 2625.5
Jan 2626.28
Jan 2626.51
Jan 2626.77
Jan 2626.84
Dec 2527.35
Dec 2526.95
Dec 2526.08
Dec 2527.13
Nov 2527.29
Nov 2526.77
Nov 2527.16
Nov 2526.19
Oct 2525.26
Oct 2523.17
Oct 2522.69
Oct 2522.46
Oct 2523.49
Sep 2523.22
Sep 2522.61
Sep 2523.65
Sep 2524.76
Aug 2524.89
Aug 2525.05
Aug 2523.88
Aug 2523.91
Aug 2523.97
Jul 2524.18
Jul 2523.04
Jul 2523.55
Jul 2523.14
Jun 2523.6
Jun 2522.18
Jun 2522.61
Jun 2523.38
May 2523.61
May 2522.56
May 2523.53
May 2522.13
May 2523.65
Apr 2523.78
Apr 2522.26
Apr 2521.54
Apr 2521.52
Mar 2522.05
Mar 2521.9
Mar 2521.5
Mar 2521.85
Feb 2522.29
Feb 2523.99
Feb 2525.03
Feb 2522.94
Jan 2523.69
Jan 2522.45
Jan 2522.73
Jan 2524.04
Jan 2524.21
Dec 2424.83
Dec 2424.53
Dec 2424
Dec 2423.36
Nov 2423.3
Nov 2422.98
Nov 2422.01
Nov 2421.46
Nov 2423.66
Oct 2424.32
Oct 2424.64
Price/Operating Cashflow
20406080100med 49.89Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2628.27
Sep 2630.12
Aug 2630.23
Aug 2630.08
Aug 2630.69
Aug 2630.06
Jul 2636.69
Jul 2635.23
Jul 2636.55
Jul 2639.31
Jul 2640.23
Jun 2638.7
Jun 2637.24
Jun 2636.28
Jun 2636.65
May 2636.86
May 2636.57
May 2634.69
May 2634.09
May 2630.56
Apr 2630.62
Apr 2629.47
Apr 2628.33
Apr 2629.49
Mar 2628.87
Mar 2630.02
Mar 2629.77
Mar 2629.7
Feb 2631.46
Feb 2645.88
Feb 2643.63
Feb 2645.26
Jan 2646.79
Jan 2648.11
Jan 2648.5
Jan 2648.95
Jan 2649.07
Dec 2549.94
Dec 2549.26
Dec 2547.77
Dec 2549.56
Nov 2549.84
Nov 2548.95
Nov 2549.63
Nov 2547.95
Oct 2560.89
Oct 2556.2
Oct 2555.12
Oct 2554.6
Oct 2556.91
Sep 2556.31
Sep 2554.95
Sep 2557.28
Sep 2559.77
Aug 2560.07
Aug 2560.43
Aug 2557.79
Aug 2557.86
Aug 2553.14
Jul 2553.59
Jul 2551.23
Jul 2552.28
Jul 2551.44
Jun 2552.39
Jun 2549.45
Jun 2550.34
Jun 2551.92
May 2552.39
May 2550.23
May 2552.25
May 2549.35
May 2582.28
Apr 2582.7
Apr 2577.8
Apr 2575.48
Apr 2575.44
Mar 2577.12
Mar 2576.63
Mar 2575.36
Mar 2576.49
Feb 2577.89
Feb 2554.28
Feb 2556.42
Feb 2552.1
Jan 2553.65
Jan 2551.09
Jan 2551.68
Jan 2554.37
Jan 2554.74
Dec 2456.02
Dec 2455.4
Dec 2454.3
Dec 2452.97
Nov 2452.84
Nov 2452.2
Nov 2450.18
Nov 2449.05
Nov 2446.95
Oct 2448.23
Oct 2448.85
Price to Book
44.555.56med 4.55Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Price to Book by year
PeriodPrice to Book
Sep 264.53
Sep 264.83
Aug 264.85
Aug 264.83
Aug 264.92
Aug 264.82
Jul 264.83
Jul 264.63
Jul 264.81
Jul 265.17
Jul 265.29
Jun 265.09
Jun 264.9
Jun 264.77
Jun 264.82
May 264.85
May 264.81
May 264.56
May 264.48
May 264.72
Apr 264.72
Apr 264.55
Apr 264.37
Apr 264.55
Mar 264.45
Mar 264.63
Mar 264.59
Mar 264.58
Feb 264.85
Feb 264.57
Feb 264.35
Feb 264.51
Jan 264.66
Jan 264.79
Jan 264.83
Jan 264.88
Jan 264.89
Dec 254.98
Dec 254.91
Dec 254.76
Dec 254.94
Nov 254.97
Nov 254.88
Nov 254.94
Nov 254.78
Oct 254.56
Oct 254.21
Oct 254.13
Oct 254.09
Oct 254.27
Sep 254.22
Sep 254.12
Sep 254.29
Sep 254.48
Aug 254.5
Aug 254.53
Aug 254.33
Aug 254.34
Aug 254.57
Jul 254.61
Jul 254.4
Jul 254.49
Jul 254.42
Jun 254.5
Jun 254.25
Jun 254.33
Jun 254.46
May 254.5
May 254.32
May 254.49
May 254.24
May 254.43
Apr 254.46
Apr 254.19
Apr 254.07
Apr 254.07
Mar 254.16
Mar 254.13
Mar 254.06
Mar 254.12
Feb 254.2
Feb 254.55
Feb 254.73
Feb 254.37
Jan 254.5
Jan 254.29
Jan 254.34
Jan 254.56
Jan 254.59
Dec 244.7
Dec 244.65
Dec 244.56
Dec 244.44
Nov 244.43
Nov 244.38
Nov 244.21
Nov 244.12
Nov 245.42
Oct 245.57
Oct 245.64
Edwards Lifesciences Corporation
EW
Stockpicker

Video analysis: EW

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EW

Edwards Lifesciences Comments on TAVR National Coverage Decision

businesswire.com · 10 Sep 2026

Edwards Lifesciences Comments on TAVR National Coverage Decision

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS):“Edwards is pleased that this updated policy represents an important step toward improving and expanding patient access to TAVR while reinforcing the value of a multidisciplinary Heart Team. Aortic stenosis is a serious, pro.

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

prnewswire.com · 7 Sep 2026

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

businesswire.com · 2 Sep 2026

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET. Doretta Mistras, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessibl.

128,603 Shares in Edwards Lifesciences Corporation $EW Acquired by Beacon Pointe Advisors LLC

defenseworld.net · 29 Aug 2026

128,603 Shares in Edwards Lifesciences Corporation $EW Acquired by Beacon Pointe Advisors LLC

Beacon Pointe Advisors LLC bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 128,603 shares of the medical research company's stock, valued at approximately $11,632,000. A number of

Is EW Overvalued? DCF Says Worth $53

gurufocus.com · 26 Aug 2026

Is EW Overvalued? DCF Says Worth $53

On August 26, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has seen a price performance of +12.4% over the past year

Bank of Nova Scotia Takes Position in Edwards Lifesciences Corporation $EW

defenseworld.net · 26 Aug 2026

Bank of Nova Scotia Takes Position in Edwards Lifesciences Corporation $EW

Bank of Nova Scotia bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 60,417 shares of the medical research company's stock, valued at approximately $5,465,000. Several other hedge funds also recently made

37,702 Shares in Edwards Lifesciences Corporation $EW Bought by EP Wealth Advisors LLC

defenseworld.net · 23 Aug 2026

37,702 Shares in Edwards Lifesciences Corporation $EW Bought by EP Wealth Advisors LLC

EP Wealth Advisors LLC bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 37,702 shares of the medical research company's stock, valued at approximately $3,410,000. Other institutional investors and hedge

B. Metzler seel. Sohn & Co. AG Buys Shares of 41,753 Edwards Lifesciences Corporation $EW

defenseworld.net · 22 Aug 2026

B. Metzler seel. Sohn & Co. AG Buys Shares of 41,753 Edwards Lifesciences Corporation $EW

B. Metzler seel. Sohn and Co. AG acquired a new position in Edwards Lifesciences Corporation (NYSE: EW) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 41,753 shares of the medical research company's stock, valued at approximately $3,777,000. Several other hedge

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.